Literature DB >> 26271226

Association of sarcopenic obesity with the risk of all-cause mortality: A meta-analysis of prospective cohort studies.

Simiao Tian1, Yang Xu1.   

Abstract

Many prospective studies have investigated the relationship between sarcopenic obesity (SO) and risk of mortality. However, the results have been controversial. The aim of the present study was to evaluate the association between SO and all-cause mortality in adults by a meta-analysis of prospective cohort studies. A systematic literature search was carried out through electronic databases up to September 2014. A total of nine articles with 12 prospective cohort studies, including 35 287 participants and 14 306 deaths, were included in the meta-analysis. Overall, compared with healthy subjects, subjects with SO had a significant increased risk of all-cause mortality (pooled HR 1.24, 95% CI 1.12-1.37, P < 0.001), with significant heterogeneity among studies (I(2)  = 53.18%, P = 0.0188), but no indication for publication bias (P = 0.7373). Heterogeneity became low and no longer significant in the subgroup analyses by three SO definitions. More importantly, SO, defined by mid-arm muscle circumference and muscle strength criteria, significantly increased the risk of mortality (HR 1.46, 95% CI 1.23-1.73 and 1.23, 1.09-1.38, respectively). The risk of all-cause mortality did not appreciably change considering the geography (USA cohorts and non-USA cohorts) or the duration of follow up (≥10 years and <10 years). However, the risk estimate was only significant in men (HR 1.23, 95% CI 1.08-1.41, P = 0.0017), not in women (HR 1.16, P = 0.1332). The results of the present study show that subjects with SO are associated with a 24% increase risk of all-cause mortality, compared with those without SO, in particular in men; the significant association was found independent of geographical location and duration of follow up.
© 2015 Japan Geriatrics Society.

Entities:  

Keywords:  all-cause mortality; meta-analysis; prospective study; sarcopenic obesity

Mesh:

Year:  2015        PMID: 26271226     DOI: 10.1111/ggi.12579

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  56 in total

Review 1.  Dietary protein and exercise for preservation of lean mass and perspectives on type 2 diabetes prevention.

Authors:  Maysa Vieira de Sousa; Diana Bento da Silva Soares; Elaine Reis Caraça; Ronaldo Cardoso
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-15

Review 2.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.

Authors:  John A Batsis; Dennis T Villareal
Journal:  Nat Rev Endocrinol       Date:  2018-09       Impact factor: 43.330

3.  Sarcopenia, Obesity and Sarcopenia Obesity in Comparison: Prevalence, Metabolic Profile, and Key Differences: Results from WCHAT Study.

Authors:  X Liu; Q Hao; J Yue; L Hou; X Xia; W Zhao; Y Zhang; M Ge; N Ge; B Dong
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

Review 4.  The translation of age-related body composition findings from rodents to humans.

Authors:  Lindsay E Pappas; Tim R Nagy
Journal:  Eur J Clin Nutr       Date:  2018-10-03       Impact factor: 4.016

5.  Sarcopenia Indicators as Predictors of Functional Decline and Need for Care among Older People.

Authors:  M Björkman; S K Jyväkorpi; T E Strandberg; K H Pitkälä; R S Tilvis
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 6.  Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives.

Authors:  Chrysi Koliaki; Stavros Liatis; Maria Dalamaga; Alexander Kokkinos
Journal:  Curr Obes Rep       Date:  2019-12

7.  Low Lean Mass With and Without Obesity, and Mortality: Results From the 1999-2004 National Health and Nutrition Examination Survey.

Authors:  John A Batsis; Todd A Mackenzie; Rebecca T Emeny; Francisco Lopez-Jimenez; Stephen J Bartels
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-01       Impact factor: 6.053

8.  Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes.

Authors:  Jürgen G Okun; Patricia M Rusu; Andrea Y Chan; Yuqin Wu; Yann W Yap; Thomas Sharkie; Jonas Schumacher; Kathrin V Schmidt; Katherine M Roberts-Thomson; Ryan D Russell; Annika Zota; Susanne Hille; Andreas Jungmann; Ludovico Maggi; Young Lee; Matthias Blüher; Stephan Herzig; Michelle A Keske; Mathias Heikenwalder; Oliver J Müller; Adam J Rose
Journal:  Nat Metab       Date:  2021-03-18

9.  Skeletal Muscle Proteomic Profile Revealed Gender-Related Metabolic Responses in a Diet-Induced Obesity Animal Model.

Authors:  Manuela Moriggi; Sara Belloli; Pietro Barbacini; Valentina Murtaj; Enrica Torretta; Linda Chaabane; Tamara Canu; Silvia Penati; Maria Luisa Malosio; Antonio Esposito; Cecilia Gelfi; Rosa Maria Moresco; Daniele Capitanio
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

10.  Incident Impaired Cognitive Function in Sarcopenic Obesity: Data From the National Health and Aging Trends Survey.

Authors:  John A Batsis; Christian Haudenschild; Robert M Roth; Tyler L Gooding; Meredith N Roderka; Travis Masterson; John Brand; Matthew C Lohman; Todd A Mackenzie
Journal:  J Am Med Dir Assoc       Date:  2020-10-21       Impact factor: 4.669

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.